AGARWAL SUNIL
Transaction: 01/23/2026
SELL
Change
-26,550
Price
$5.79
Filing
01/23/2026
Type
SELL
Astria Therapeutics, Inc.
ATXS • Biotechnology
$12.58
— 0.00 (0.00%)
EarningsLatest report: Sep 30, 2025
HIGHER-RISK PROFILECautionConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$729.71M
Growth
—
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0.02Healthy liquidity · 17.49Weak profitability
Financial data as of: Sep 30, 2025, 12:00 AM UTCLast earnings update: Nov 12, 2025, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:27 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$12.58
Change0.00%
Shares Out58.01M
Market Cap$729.71M
Enterprise Value$501.99M
52W Range3.56 - 13.29
Beta0.02
P/E-5.88
P/S1,033.58
P/B3.13
P/FCF-6.06
EV/Sales711.03
Price$12.58
Change0.00%
Shares Out58.01M
Market Cap$729.71M
Enterprise Value$501.99M
52W Range3.56 - 13.29
Beta0.02
P/E-5.88
P/S1,033.58
P/B3.13
P/FCF-6.06
EV/Sales711.03
EV/EBITDA-3.74
EV/FCF-4.17
Earnings Yield-17.00%
FCF Yield-16.49%
Dividend Yield0.00%
Gross Margin0.00%
Oper. Margin0.00%
Profit Margin0.00%
Debt/Eq0.02
Current Ratio17.49
Quick Ratio17.49
Target$19.40
Target Upside54.21%
Target Median$20.00
Target Range13.00 - 26.00
Volume3.06M
Avg Volume1.07M
EPS Surprise-0.14
Investment DNA
How strong this company looks for long-term investors
47
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
50/100
Price Attractiveness
Cheap or expensive today
90/100
Why this score▼
Manageable debt level · 0.02Healthy liquidity · 17.49Weak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 8 analyst votes · 2026-09-04
69/100
Neutral
Bullish
3
Hold
5
Bearish
0
Price Target
2026-06-06
Low
$13.00
Mean
$19.40
Median
$20.00
High
$26.00
Insider Transactions
Recent executive and insider activity
⚠ 7 high-volume insider sells detected
BATE KENNETH
Transaction: 01/23/2026
SELL
Change
-14,100
Price
$11.35
Filing
01/23/2026
Type
SELL
Beck Joanne T.
Transaction: 01/23/2026
SELL
Change
-14,100
Price
$11.35
Filing
01/23/2026
Type
SELL
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| AGARWAL SUNIL | SELL | -26,550 | $5.79 | 01/23/2026 | 01/23/2026 |
| BATE KENNETH | SELL | -14,100 | $11.35 | 01/23/2026 | 01/23/2026 |
| Beck Joanne T. | SELL | -14,100 | $11.35 | 01/23/2026 | 01/23/2026 |
| Callori Fred | SELL | -26,550 | $5.79 | 01/23/2026 | 01/23/2026 |
| Clauser Noah | SELL | -262,500 | $6.41 | 01/23/2026 | 01/23/2026 |
| Cole Hugh M | SELL | -14,100 | $9.18 | 01/23/2026 | 01/23/2026 |
| Harshbarger Benjamin | SELL | -262,500 | $6.41 | 01/23/2026 | 01/23/2026 |
| KISHBAUCH MICHAEL D | SELL | -8,333 | $3.00 | 01/23/2026 | 01/23/2026 |
| Komjathy Andrew | SELL | -45 | Not reported | 01/23/2026 | 01/23/2026 |
| Komjathy Andrew | SELL | -225,000 | $6.41 | 01/23/2026 | 01/23/2026 |
| LAPOINTE ANTHONY GREGG | SELL | -26,550 | $5.79 | 01/23/2026 | 01/23/2026 |
| Matthews Andrea | SELL | -262,500 | $6.41 | 01/23/2026 | 01/23/2026 |
| Milne Jill C. | SELL | -4,377 | Not reported | 01/23/2026 | 01/23/2026 |
| Milne Jill C. | SELL | -195,000 | $6.51 | 01/23/2026 | 01/23/2026 |
| Morabito Christopher | SELL | -262,500 | $6.41 | 01/23/2026 | 01/23/2026 |
| Violin Jonathan | SELL | -263,321 | Not reported | 01/23/2026 | 01/23/2026 |
| Violin Jonathan | BUY | +26,550 | $5.79 | 01/23/2026 | 01/23/2026 |
| Callori Fred | BUY | +26,550 | $5.79 | 06/11/2025 | 06/12/2025 |
| Beck Joanne T. | BUY | +26,550 | $5.79 | 06/11/2025 | 06/12/2025 |
| Violin Jonathan | BUY | +26,550 | $5.79 | 06/11/2025 | 06/12/2025 |